Simple Summary Patients with liver metastases can be scheduled for different therapies (eg,
chemotherapy, surgery, radiotherapy, and ablation). The choice of the most appropriate …

Background: Although many works have supported the utility of PET radiomics, several
authors have raised concerns over the robustness and replicability of the results. This study …

The NETTER-1 study has proven peptide receptor radionuclide therapy (PRRT) to be one of
the most effective therapeutic options for metastatic neuroendocrine tumors (NETs) …

Simple Summary The monitoring of disease in patients with neuroendocrine tumors is
challenging and requires specialized imaging techniques. To address these quests …

Nuclear medicine has acquired a crucial role in the management of patients with
neuroendocrine neoplasms (NENs) by improving the accuracy of diagnosis and staging as …

Numerous researchers and scientists are trying to develop novel methods and technologies
to treat cancers more efficiently and quickly. One of the most important steps to treat cancers …

The origin of metastatic liver tumours (arising from gastric or colorectal sources) is closely
linked to treatment choices and survival prospects. However, in some instances, the primary …

Objective To identify the impact of segmentation methods and intensity discretization on
radiomic features (RFs) extraction from 68 Ga-DOTA-TOC PET images in patients with …

The objective of this review was to summarize published radiomics studies dealing with
infradiaphragmatic cancers, blood malignancies, melanoma, and musculoskeletal cancers …

Molecular imaging plays a vital role in the management of neuroendocrine neoplasms
(NENs). Somatostatin receptor (SSTR) PET is critical for evaluating NENs, ascertaining …